Article
T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications.
Blood - 1 Jul 1990
Anderson K C, Soiffer R, DeLage R, Takvorian T, Freedman A S, Rabinowe S L, Nadler L M, Dear K, Heflin L, Mauch P
Abstract excerpt
Fourteen patients with T-cell-derived leukemia and lymphoma underwent high-dose chemoradiotherapy and anti-T-cell monoclonal antibody-treated autologous bone marrow transplantation (ABMT). All patients were either in sensitive relapse or had adverse prognostic features, and five patients had a history of bone marrow involvement with disease. Patients received a median of 2 (1 to 3) prior chemotherapy regimens; 10...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.